COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Proactive Care Coordination for Cancer Survivors Who Smoke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02723656
Recruitment Status : Completed
First Posted : March 30, 2016
Last Update Posted : December 11, 2018
Information provided by (Responsible Party):
NYU Langone Health

Brief Summary:
This is a population-based randomized controlled trial of 600 patients with a diagnosis of cancer in the past 2 years and registry indicating smoking at the time of diagnosis, that will inform critical questions regarding the relative efficacy of care coordination options, the reliability of Electronic Health Record (EHR) tobacco use data, and how patients will react to proactive tobacco related communications. Investigators will compare the reach and efficacy of two proactive approaches to enrolling cancer survivors in tobacco treatment (Arm 1: mailed care coordination vs. Arm 2: telephone care coordination) using a two-arm randomized design at two urban cancer centers, and will explore cancer survivor attitudes and preferences about proactive tobacco treatment.

Condition or disease Intervention/treatment Phase
Cancer Behavioral: Online Referral NYS Quitline Behavioral: Tobacco cessation counseling and coordination of cessation medications Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 581 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Using Cancer Registry Data to Promote Proactive Tobacco Cessation Among Adult Cancer Survivors U48
Study Start Date : March 2016
Actual Primary Completion Date : September 29, 2018
Actual Study Completion Date : September 29, 2018

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: Proactive mailed care coordination Behavioral: Online Referral NYS Quitline
Care coordinator will make an online referral to the NYS Quitline.

Active Comparator: Proactive telephone care coordination. Behavioral: Tobacco cessation counseling and coordination of cessation medications
Care coordinator will obtain verbal consent to transfer the patient to the NYS Quitline via 3-way call (warm transfer). The care coordinator will also assist the patient in obtaining NRT from a regular care provider, then call the patient every three months for 12 months to assess current smoking and offer to help smokers obtain additional cessation counseling and medications.

Primary Outcome Measures :
  1. Proportion of patients in the study's original proactive outreach cohort of N=600 who complete at least one call with the Quitline [ Time Frame: 12 Months ]

Secondary Outcome Measures :
  1. biochemically validated 7-day abstinence [ Time Frame: 6 Months, 12 Months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • ICD 9 cancer diagnosis seen at each site in the past two years
  • Documentation of current smoking in the cancer registry.

Exclusion Criteria:

  • Dementia
  • Stage IV or Stage IIIB cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02723656

Layout table for location information
United States, New York
New York University School of Medicine
New York, New York, United States, 10016
Sponsors and Collaborators
NYU Langone Health
Layout table for investigator information
Principal Investigator: Paul Krebs, MD New York University Medical School
Layout table for additonal information
Responsible Party: NYU Langone Health Identifier: NCT02723656    
Other Study ID Numbers: 15-01069
First Posted: March 30, 2016    Key Record Dates
Last Update Posted: December 11, 2018
Last Verified: December 2018
Keywords provided by NYU Langone Health:
cancer registry
smoking cessation